Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration
Abstract A deeper understanding of early disease mechanisms occurring in Parkinson’s disease (PD) is needed to reveal restorative targets. Here we report that human induced pluripotent stem cell (iPSC)-derived dopaminergic neurons (DAn) obtained from healthy individuals or patients harboring LRRK2 P...
Guardado en:
Autores principales: | G. Carola, D. Malagarriga, C. Calatayud, M. Pons-Espinal, L. Blasco-Agell, Y. Richaud-Patin, I. Fernandez-Carasa, V. Baruffi, S. Beltramone, E. Molina, P. Dell’Era, J. J. Toledo-Aral, E. Tolosa, A. R. Muotri, J. Garcia Ojalvo, J. Soriano, A. Raya, A. Consiglio |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7c8c8c544c2b4347a40c5da25a5f23b4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding.
por: Jean-Marc Taymans, et al.
Publicado: (2011) -
Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels
por: Rubén Fernández-Santiago, et al.
Publicado: (2021) -
LRRK2 levels in immune cells are increased in Parkinson’s disease
por: D. A. Cook, et al.
Publicado: (2017) -
Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes
por: Kushal Sejwal, et al.
Publicado: (2017) -
Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10
por: Xiang Wang, et al.
Publicado: (2021)